Anti-SARS-CoV-2 RBD Human Monoclonal Antibody [clone: R323IgM]

Supplier: Genscript
GenScript®
A02088-1 A02088-100
77007-580EA 3197.7 USD
77007-580 77007-562
Anti-SARS-CoV-2 RBD Human Monoclonal Antibody [clone: R323IgM]
Antibodies
SARS-CoV-2 (Severe acute respiratory syndrome coronavirus 2), also known as 2019-nCoV, is a positive-sense single-stranded RNA virus. It caused coronavirus disease 2019 (COVID-19). SARS-CoV-2 contains glycosylated spike (S) protein, which is composed of S1 subunit and S2 subunit. The S1 contains a receptor-binding domain (RBD) that can bind to ACE2 receptor on target cells.SARS-CoV-2 Neutralizing Antibody (R323IgM), Human Chimeric is produced from cell culture in vitro under conditions free from animal-derived components.

  • High specificity
  • High affinity
  • High stability

Genscript offers site-specific neutralizing antibodies, neutralizing antibody standards, and control antibodies.

Type:
Antigen: SARS-CoV-2 RBD
Clonality: Monoclonal
Clone: R323IgM
Conjugation: Unconjugated
Epitope:
Host: Human
Isotype: IgM
Reactivity:
Order Now

Learn more

About VWR

Avantor is a vertically integrated, global supplier of discovery-to-delivery solutions for...

Learn more About VWR